From: Cannabidiol as a novel therapeutic agent in breast cancer: evidence from literature
Treatment Modality | Advantages | Limitations |
---|---|---|
CBD-based Therapy | Minimal toxicity, potential anti-metastatic effects, modulation of tumor microenvironment | Lack of standardized clinical data, regulatory concerns |
Chemotherapy | Effective tumor shrinkage, established clinical use | Severe side effects (nausea, neuropathy, immune suppression) |
Targeted Therapy (HER2 inhibitors, PARP inhibitors) | Specific inhibition of cancer-related pathways | High cost, resistance development |
Immunotherapy (PD-1/PD-L1 inhibitors) | Enhances immune response against tumors | Variable response rates, immune-related adverse events |